IndraLab
Statements
sparser
"Given that JQ1 induces upregulation of DUB3 at both mRNA and protein levels in different cell types ( xref ) ( xref ) and DUB3 binds to BRD4 and promotes its deubiquitination and protein stabilization ( xref and xref ), we sought to determine whether JQ1-induced stabilization of BRD4 is mediated through upregulation of active DUB3."
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
USP17L2 is modified
|
21
17
USP17L2 is phosphorylated.
|
20
17
rlimsp
"We found that Ser41 is a major phosphorylation site on DUB3, which matches with a CDK consensus motif (Supplementary Fig. 6b). To test whether S41 is a CDK4/6 phosphorylation site, GST-fused WT DUB3 and S41A mutants were incubated with active CDK4 or CDK6 and an in vitro kinase assay was performed. As shown in Fig. 5d, mutation at S41 abolished CDK4/6-mediated phosphorylation of DUB3 in vitro. A phospho-Ser41-specific antibody was generated to further study the phosphorylation of Ser41 in cells."
rlimsp
"We next tested how CDK4/6 and S41 phosphorylation of DUB3 affects SNAIL1 ubiquitination. We transfected cells with FLAG-DUB3 and HA-SNAIL1, treated cells with vehicle or CDK4/6 inhibitor PD0332991, and SNAIL1 ubiquitination was determined. As shown in Fig. 6a, SNAIL1 ubiquitination was stronger in cells treated with PD0332991 compared to vehicle, suggesting that CDK4/6 activity is important for the catalytic activity of DUB3. We further tested whether phosphorylation of S41 on DUB3 could affect the ubiquitination of SNAIL1 in cells. As shown in Fig. 6b,c, overexpression of both WT and S41D mutant DUB3 in cells efficiently decreased the ubiquitination of SNAIL1; however, S41A mutant failed to do so. Collectively, these results suggest that phosphorylation of S41 is important for the deubiquitinase activity of DUB3 towards SNAIL1."
sparser
"In agreement with the recent report that the deubiquitination activity of DUB3 relies on CDK4/6-mediated phosphorylation of DUB3 and this activity is inhibited by the CDK4/6 inhibitor ( xref ), we demonstrated that treatment of mice with the CDK4/6 inhibitor palbociclib largely sensitized DUB3-proficient prostate tumors to JQ1, but the effect of palbociclib was almost completely abolished by DUB3 knockdown."
USP17L2 is ubiquitinated.
|
1
sparser
"Given that JQ1 induces upregulation of DUB3 at both mRNA and protein levels in different cell types ( xref ) ( xref ) and DUB3 binds to BRD4 and promotes its deubiquitination and protein stabilization ( xref and xref ), we sought to determine whether JQ1-induced stabilization of BRD4 is mediated through upregulation of active DUB3."
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
USP17L2 affects cell population proliferation
|
2
16
USP17L2 inhibits cell population proliferation.
|
10
USP17L2 inhibits cell population proliferation. 10 / 10
|
10
reach
"More recently, we have also reported that constitutive expression of DUB-3 can block cell proliferation [XREF_BIBR, XREF_BIBR] and subsequently we have demonstrated that this is due to its regulation of the ubiquitination and activity of the ' CAAX ' box protease Ras converting enzyme 1 (RCE1) [XREF_BIBR]."
reach
"In particular, DUB-1 expression results in cell cycle arrest prior to S-phase [XREF_BIBR], DUB-2 expression markedly inhibits apoptosis induced by cytokine withdrawal [XREF_BIBR] and we have previously reported that constitutive expression of DUB-3 blocks cell proliferation [XREF_BIBR, XREF_BIBR, XREF_BIBR] through its regulation of the ubiquitination and activity of the ' CAAX ' box protease RCE1 [XREF_BIBR, XREF_BIBR]."
USP17L2 activates cell population proliferation.
|
2
6
USP17L2 affects Snail1
|
17
USP17L2 affects Neoplasm Metastasis
|
3
10
USP17L2 activates Neoplasm Metastasis.
|
3
8
USP17L2 activates Neoplasm Metastasis. 10 / 11
|
3
8
eidos
"It has been reported that Snail1 pathway is involved in the progression of many diseases , for instance , Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.25 CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.26 Moreover , it has been reported that Snail1 has involved the progression of DN.27 Consistent with our research , mRNA and protein expression of Snail1 was decreased in PVT1-KD MCs , which was reversed by treating with miR-325-3p inhibitor ."
eidos
"USP17 Knockdown Impairs Tumor Proliferation and Metastasis Through Targeting MMPs Because degradation of the basement membrane by MMPs is required for tumor cell migration and invasion ( 16,17 ) , we sought to determine whether MMPs were responsible for USP17-dependent growth and invasion ."
USP17L2 inhibits Neoplasm Metastasis.
|
2
USP17L2 affects Neoplasm Invasiveness
|
3
9
USP17L2 activates Neoplasm Invasiveness.
|
3
7
USP17L2 activates Neoplasm Invasiveness. 9 / 9
|
3
6
eidos
"Suppression of Ubiquitin-Specific Peptidase 17 ( USP17 ) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells USP17 PROMOTES TUMORIGENESIS AND METASTASIS IN NSCLC ZHANG , YUAN , AND ZHENG Recently , deubiquitinating enzymes ( DUBs ) are emerging as new regulators in cancer progression ."
USP17L2 bound to SNAI1 activates Neoplasm Invasiveness. 1 / 1
|
1
USP17L2 inhibits Neoplasm Invasiveness.
|
2
|
8
USP17L2 activates epithelial to mesenchymal transition. 8 / 8
|
8
reach
"In fact, DUBs involved in Snail regulation so far are shown to be induced differently, while USP27x is induced by TGF-β; DUB3/USP17L2 seems to play a role in CDK4/6-mediated activation of EMT, whereas OTUB1 is under the transcriptional regulation of oestrogen-related receptor alpha, and USP37 regulation is induced during EMT via the stimulation of the hedgehog signalling pathway."
USP17L2 affects apoptotic process
|
8
USP17L2 activates apoptotic process.
|
5
USP17L2 inhibits apoptotic process.
|
3
USP17L2 affects SNAIL1
|
7
"We previously reported that the USP17 deubiquitinating enzyme having hyaluronan binding motifs (HABMs) interacts with human SDS3 (suppressor of defective silencing 3) and specifically deubiquitinates Lys-63 branched polyubiquitination of SDS3 resulting in negative regulation of histone deacetylase (HDAC) activity in cancer cells."
WP1130 affects USP17L2
|
1
4
reach
"As expected, only wild type Esrrb and not the C-terminally truncated receptor increased Dub3 transcriptional activity (XREF_FIG), indicating that coactivator recruitment through the C-terminus that contains the AF2 domain is essential to the Esrrb mediated transcriptional response on the Dub3 promoter."
USP17L2 affects cell migration
|
1
3
USP17L2 affects SNAIL1 protein
|
4
USP17L2 affects Neoplastic Stem Cells
|
4
USP17L2 activates Neoplastic Stem Cells.
|
3
USP17L2 activates Neoplastic Stem Cells. 2 / 2
|
2
USP17L2 bound to SNAI1 activates Neoplastic Stem Cells. 1 / 1
|
1
USP17L2 inhibits Neoplastic Stem Cells.
|
1
USP17L2 inhibits Neoplastic Stem Cells. 1 / 1
|
1
USP17L2 affects Carcinogenesis
|
4
USP17L2 activates Carcinogenesis. 4 / 4
|
4
eidos
"Suppression of Ubiquitin-Specific Peptidase 17 ( USP17 ) Inhibits Tumorigenesis and Invasion in Non-Small Cell Lung Cancer Cells USP17 PROMOTES TUMORIGENESIS AND METASTASIS IN NSCLC ZHANG , YUAN , AND ZHENG Recently , deubiquitinating enzymes ( DUBs ) are emerging as new regulators in cancer progression ."
Snail1 affects USP17L2
|
4
sparser
"Importantly, it has been shown recently in breast cancer cells that DUB3 can be phosphorylated by CYCLIN-dependent kinases 4 and 6 (CDK4/6) and this phosphorylation is essential for the deubiquitinase activity of DUB3 ( xref ), highlighting that DUB3 is a druggable target for cancer therapy."
USP17L2 affects cell differentiation
|
3
USP17L2 inhibits cell differentiation.
|
2
USP17L2 activates cell differentiation.
|
1
USP17L2 activates cell differentiation. 1 / 1
|
1
USP17L2 affects breast cancer invasion
|
3
eidos
"It has been reported that Snail1 pathway is involved in the progression of many diseases , for instance , Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.25 CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.26 Moreover , it has been reported that Snail1 has involved the progression of DN.27 Consistent with our research , mRNA and protein expression of Snail1 was decreased in PVT1-KD MCs , which was reversed by treating with miR-325-3p inhibitor ."
USP17L2 affects WP1130
|
3
Interleukin affects USP17L2
|
2
Cisplatin treatment affects USP17L2
|
2
USP17L2 affects protein
|
2
USP17L2 affects macrophage-promoted inflammation stemness lung cancer cells
|
2
USP17L2 affects homologous recombination
|
2
USP17L2 affects cell growth
|
1
1
USP17L2 affects cell cycle
|
2
USP17L2 inhibits cell cycle.
|
1
USP17L2 inhibits cell cycle. 1 / 1
|
1
USP17L2 activates cell cycle.
|
1
USP17L2 activates cell cycle. 1 / 1
|
1
reach
"More recently, we have also reported that constitutive expression of DUB-3 can block cell proliferation [XREF_BIBR, XREF_BIBR] and subsequently we have demonstrated that this is due to its regulation of the ubiquitination and activity of the ' CAAX ' box protease Ras converting enzyme 1 (RCE1) [XREF_BIBR]."
USP17L2 affects Hippo
|
2
USP17L2 affects Hemagglutinins
|
2
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
USP17L2 affects DNA Breaks, Double-Stranded
|
2
USP17L2 inhibits DNA Breaks, Double-Stranded.
|
1
USP17L2 inhibits DNA Breaks, Double-Stranded. 1 / 1
|
1
USP17L2 activates DNA Breaks, Double-Stranded.
|
1
USP17L2 activates DNA Breaks, Double-Stranded. 1 / 1
|
1
SNAIL1 affects USP17L2
|
2
Hemagglutinins affects USP17L2
|
2
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
DY131 affects USP17L2
|
2
BRD4 affects Hemagglutinins
|
2
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
Valproic acid affects USP17L2
1
|
SiDub3-3 affects USP17L2
|
1
SiDub3-2 affects USP17L2
|
1
SiDub3-1 affects USP17L2
|
1
Rifampicin affects USP17L2
1
|
Pristimerin treatment affects USP17L2
|
1
Paracetamol affects USP17L2
1
|
Palbociclib affects USP17L2
|
1
Palbociclib activates USP17L2. 1 / 1
|
1
Overexpression miR-542-5p pristimerin treatment affects USP17L2
|
1
Homologous recombination affects USP17L2
|
1
Homologous recombination activates USP17L2. 1 / 1
|
1
Histone deacetylase inhibitors affects USP17L2
|
1
Cadmium atom affects USP17L2
1
|
Arrangement affects USP17L2
|
1
USP17L2 affects virus-induced
|
1
USP17L2 affects virus-induced IFN-I
|
1
USP17L2 affects viability
|
1
USP17L2 affects tumorigenesis invasion NSCLC cells
|
1
USP17L2 affects tumorigenesis NSCLC cells
|
1
USP17L2 affects tumorigenesis NSCLC cell lines A549
|
1
USP17L2 affects tumor processes
|
1
USP17L2 affects transcriptional
|
1
USP17L2 affects transcription, DNA-templated
|
1
USP17L2 activates transcription, DNA-templated. 1 / 1
|
1
USP17L2 affects trafficking lysosomes cell periphery
|
1
USP17L2 affects stability
|
1
USP17L2 affects receptor cell surface
|
1
USP17L2 affects pulmonary nodules Fig. 5A-C tumor
|
1
USP17L2 affects processes
|
1
USP17L2 affects process
|
1
USP17L2 affects plasma membrane repair cells treated pore-forming toxin streptolysin O
|
1
USP17L2 affects phosphorylation downstream kinases MEK
|
1
USP17L2 affects peripheral lysosome positioning
|
1
USP17L2 affects oestrogen receptor
|
1
USP17L2 activates oestrogen receptor. 1 / 1
|
1
USP17L2 affects metastasis.25 analysis
|
1
USP17L2 affects invasion capacity
|
1
USP17L2 affects invasion NSCLC cells
|
1
USP17L2 affects invading capacity cells
|
1
USP17L2 affects induction IFNs
|
1
USP17L2 affects hydrolysis fluorogenic peptide substrate RLRGG-AMC modifier substrate ISG15-AMC
|
1
USP17L2 affects hydrolysis Ub-AMC
|
1
USP17L2 affects growth cells
|
1
USP17L2 affects glycolytic process
|
1
USP17L2 activates glycolytic process. 1 / 1
|
1
USP17L2 affects deubiquitination stabilization HDAC2 cigarette smoke extract-induced inflammation
|
1
USP17L2 affects depending
|
1
USP17L2 affects cellular EMT transcription SNAIL1
|
1
USP17L2 affects cell death
|
1
USP17L2 activates cell death. 1 / 1
|
1
reach
"Inhibition of USP27X enhanced cell death promoted by exposition to cisplatin [5], opening the possibility to use small molecules against this enzyme to restore or potentiate chemosensitivy to cisplatin or other drugs.Recently, Dub3 was also described as a deubiquitinase of Snail1 [9]."
USP17L2 affects calculated molecular
|
1
USP17L2 affects beta-TRCP1
|
1
USP17L2 affects anchorage-independent growth invasion NSCLC cells
|
1
USP17L2 affects acute mRNA STAT3-inducible STAT3
|
1
USP17L2 affects activity
|
1
reach
"More recently, we have also reported that constitutive expression of DUB-3 can block cell proliferation [XREF_BIBR, XREF_BIBR] and subsequently we have demonstrated that this is due to its regulation of the ubiquitination and activity of the ' CAAX ' box protease Ras converting enzyme 1 (RCE1) [XREF_BIBR]."
USP17L2 affects PI3K AKT pathway
|
1
USP17L2 affects Nrf2 stability
|
1
USP17L2 affects NSCLC
|
1
USP17L2 affects NSCLC tumorigenesis
|
1
USP17L2 affects NSCLC cells wild-type
|
1
USP17L2 affects MMPs cells
|
1
USP17L2 affects LATS1/2
|
1
USP17L2 affects LATS proteins
|
1
USP17L2 affects K-Ras membrane trafficking
|
1
USP17L2 affects ISOFORM
|
1
USP17L2 affects Histone_H2B
|
1
USP17L2 leads to the ubiquitination of Histone_H2B. 1 / 1
|
1
USP17L2 affects G1-S phase transition
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
USP17L2 affects ER
|
1
USP17L2 affects EGF-induced H-Ras
|
1
USP17L2 affects DNA damage checkpoint
|
1
USP17L2 activates DNA damage checkpoint. 1 / 1
|
1
USP17L2 affects DNA Damage
|
1
USP17L2 activates DNA Damage. 1 / 1
|
1
USP17L2 affects Colony Potential Lines investigate biological functions USP17 transformation cells
|
1
USP17L2 activates Colony Potential Lines investigate biological functions USP17 transformation cells. 1 / 1
|
1
eidos
"USP17 Inhibition Reduces Cell Colony Formation Potential in NSCLC Cell Lines To investigate the biological functions of USP17 in the transformation of NSCLC cells , we conducted soft agar colony formation assay to determine the anchorage-independent growth and tumorigenesis abilities of the NSCLC cell lines A549 ( Fig. 2A and B ) and H1299 ( Fig. 2C and D ) ."
USP17L2 affects BRD4DeltaCTM mutant
|
1
USP17L2 affects BRD4 deubiquitination stabilization various cancer cell lines
|
1
PTC596 affects USP17L2
|
1
Overexpression miR-542-5p breast cancer cells affects USP17L2
|
1
NCOR2-HDAC10 affects USP17L2
|
1
LATS1/2 affects USP17L2
|
1
LATS1/2 proteins affects USP17L2
|
1
LATS1/2 kinases affects USP17L2
|
1
K value associated USP17 affects USP17L2
|
1
IL-6-mediated inflammation affects USP17L2
|
1
IL-)4 affects USP17L2
|
1
Hemagglutinins affects Flag
|
1
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
Hemagglutinins affects FlaG
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
HDACis affects USP17L2
|
1
HDAC inhibitors affects USP17L2
|
1
Flag affects Hemagglutinins
|
1
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
ERRbeta knockdown affects USP17L2
|
1
CDK4/6 inhibitor affects USP17L2
|
1
BRD4 affects Flag, Hemagglutinins, and USP17L2
|
1
BRD4 binds USP17L2, Hemagglutinins, and Flag. 1 / 1
|
1
BRD4 affects FlaG, Hemagglutinins, and USP17L2
|
1
BRD4 binds USP17L2, Hemagglutinins, and FlaG. 1 / 1
|
1
BMI-1 siRNA affects USP17L2
|
1
Air Pollutants affects USP17L2
1
|
2-hydroxypropanoic acid affects USP17L2
1
|